Your browser doesn't support javascript.
loading
Clinical outcomes of immune checkpoint inhibitor therapy for advanced lung adenosquamous carcinoma.
Wei, Jingwen; Xiang, Jing; Hao, Yue; Si, Jinfei; Gu, Xiaodong; Xu, Manyi; Song, Zhengbo.
Afiliación
  • Wei J; Department of Clinical Trial, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Xiang J; Wenzhou Medical University, Wenzhou, China.
  • Hao Y; Department of Clinical Trial, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Si J; The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.
  • Gu X; Department of Clinical Trial, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Xu M; The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.
  • Song Z; Department of Clinical Trial, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
J Thorac Dis ; 15(2): 260-269, 2023 Feb 28.
Article en En | MEDLINE | ID: mdl-36910045
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: J Thorac Dis Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: J Thorac Dis Año: 2023 Tipo del documento: Article País de afiliación: China